Abu Dhabi-based Mubadala Investment Company has joined hands with Swedish private equity EQT to acquire Envirotainer, the leading global provider of mission-critical, proprietary temperature-controlled supply chain solutions for the transportation of biopharmaceuticals.

 

The duo today (June 7) signed an agreement with international private equity firm Cinven and co-investor Novo Holdings thus closing the acquistion deal for an enterprise value of €2.8 billion ($2.9 billion).

 

EQT Private Equity and Mubadala will seek to support Envirotainer in its next growth phase by accelerating expansion in APAC and continuing stable growth in its other core markets. 

 

They will leverage EQT’s local-with-locals approach and Mubadala’s global network to do so. Both investors will help scale the newly-launched CryoSure offering and continue the successful roll-out of third-generation Releye containers while investing in new technology innovations, digitalisation, and sustainability in its operations.

 

Millions of people across the globe depend on the safe delivery of biopharmaceuticals that require temperature control to maintain their integrity and quality, said the statement from Mubadala. 

 

Today, lack of access to medicines is a cause of the distress that impacts underserved communities, whose situation is likely to be exacerbated by chronic diseases resulting from changing diets and lifestyles, and air and water pollution. 

Envirotainer expands access to vital pharmaceuticals and vaccines through its patient-safe, reliable and efficient cold chain solutions, which are the most climate-neutral offering in the industry.

 

Camilla Macapili Languille, Head of Life Sciences at Mubadala, said: "Envirotainer plays a mission-critical role in the healthcare ecosystem by ensuring the safe and reliable delivery of drugs from pharma companies to hospitals, clinics, and ultimately, patients."

 

"Their extensive international footprint ideally positions Envirotainer to meet the pharma industry’s growing need for global temperature-controlled distribution. As the undisputed market leader, they are continuing to pioneer developments in the sector with forward-thinking R&D innovation," he noted.

 

Ali Farahani, Partner within EQT Private Equity’s Advisory Team, said, "Envirotainer is the clear global leader with significant scale advantages, superior operations and industry-leading performance. Moreover, the company has a clear purpose of enabling access to life-saving pharmaceuticals and offers reusable solutions with significantly less CO2 emissions compared to traditional solutions."

 

Envirotainer was founded in 1985 in Stockholm, Sweden, where its headquarters, R&D and production facilities are based. Envirotainer designs, manufactures and leases active temperature-controlled containers used primarily for air freighting biopharma products.

 

"With a fleet of 6,700 containers globally and approximately 375 employees in 20 countries, the company is the global leader in active temperature control for air transportation of temperature-sensitive pharmaceuticals. It has more than 600 customers worldwide, including many global blue-chip pharma and biotech companies," he added.-TradeArabia News Service